TripleMed

Netherlands
Maastricht, Limburg, The Netherlands, 6229 EV

Company profile

TripleMed company profile

TripleMed is developing minimally invasive products against aneurysms, without the need for incisions. The first product fills the aneurysm and prevents blood from entering, whilst leaving a channel for the blood to flow through to reach the other arteries. This enables a better and longer-lasting solution to the problem of aortic aneurysms.

Business identity

Contact email
[email protected]
Operating status
Active
Company type
For Profit
Employee range
1-10 employees
Revenue range
$0-$1M
Founded
2011-01-01, Year

Headquarters

Postal code
6229 EV
Country code
NL
Continent
Europe

Capital profile

Funding and company signals

Funding stage
Early Stage Venture
Funding rounds
1
Total equity funding
$2.4M
Last funding
Series A / $2.4M / 2017-09-18
Last equity funding
Series A / $2.4M
Investors
2
Lead investors
1
Founders
2

Founders and investors

Founders

Hans BromMichael Jacobs

Lead investors

Chemelot Ventures

Investors

Chemelot VenturesLimburg Business Development Fund (LBDF)